Consistent with previous research,21, 47 we found less hippocampal atrophy in VR tau‐PET‐negative AD patients compared to tau‐PET positive ones but a lower hippocampal volume compared to both control groups, indicating an ongoing neurodegenerative process. The gene discussed is MAPT; the disease is Alzheimer disease.